Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Open questions in the management of mesothelioma

Biomarker-selected therapy: Progress or delusion?

Date

21 Oct 2023

Session

Open questions in the management of mesothelioma

Topics

Tumour Site

Mesothelioma

Presenters

Paul Baas

Authors

P. Baas

Author affiliations

  • Thoracic Oncology Dept, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1066 CX - Amsterdam/NL

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

When and when not to operate

Presenter: Jean Yannis Perentes

Session: Open questions in the management of mesothelioma

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: Open questions in the management of mesothelioma

Resources:

Slides

Webcast

Conclusions and perspectives 

Presenter: Jean Yannis Perentes

Session: Open questions in the management of mesothelioma

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.